Illume Fertility – FDA 483, May 8, 2026
Illume Fertility in Norwalk, CT, a reproductive human tissue establishment, was cited for two observations during an FDA inspection. The firm failed to maintain proper records for anonymous oocyte donors, as donor names were found in accompanying documentation. Additionally, the inspection revealed significant deficiencies in the labeling of HCT/Ps, including fertilized oocytes and semen, which lacked required warning statements regarding donor screening, testing status, autologous use, and communicable disease risks.
ID · c80a9ef6-5218-4042-98f2-eaeba8573d2c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.